Comment on "Myosteatosis and Muscle Loss Impact Liver Transplant Outcomes in Male Patients With Hepatocellular Carcinoma" by Lu et al.-The Authors' Reply.
作者信息
Lu Di, Hu Zhihang, Chen Hao, Xu Xiao
机构信息
Department of Hepatobiliary & Pancreatic Surgery and Minimally Invasive Surgery, Zhejiang Provincial People's Hospital, Affiliated People's Hospital of Hangzhou Medical College, Hangzhou, China.
NHC Key Laboratory of Combined Multi-Organ Transplantation, Hangzhou, China.
出版信息
J Cachexia Sarcopenia Muscle. 2025 Apr;16(2):e13762. doi: 10.1002/jcsm.13762.
Abstract
摘要
相似文献
1
Comment on "Myosteatosis and Muscle Loss Impact Liver Transplant Outcomes in Male Patients With Hepatocellular Carcinoma" by Lu et al.-The Authors' Reply.
J Cachexia Sarcopenia Muscle. 2025 Apr;16(2):e13762. doi: 10.1002/jcsm.13762.
2
Comment on 'Myosteatosis and Muscle Loss Impact Liver Transplant Outcomes in Male Patients With Hepatocellular Carcinoma' by Lu et al.
J Cachexia Sarcopenia Muscle. 2024 Dec;15(6):2877-2878. doi: 10.1002/jcsm.13620. Epub 2024 Oct 20.
3
Myosteatosis and muscle loss impact liver transplant outcomes in male patients with hepatocellular carcinoma.
J Cachexia Sarcopenia Muscle. 2024 Oct;15(5):2071-2083. doi: 10.1002/jcsm.13554. Epub 2024 Aug 27.
4
Different cutoff values of the skeletal muscle mass and myosteatosis result in different clinical impact on overall survival in oncology. A subanalysis of a clinical trial.
J Cancer Res Clin Oncol. 2025 Apr 16;151(4):141. doi: 10.1007/s00432-025-06190-1.
5
Myosteatosis, the More Significant Predictor of Outcome: An Analysis of the Impact of Myosteatosis, Sarcopenia, and Sarcopenic Obesity on Liver Transplant Outcomes in Johannesburg, South Africa.
Exp Clin Transplant. 2021 Sep;19(9):948-955. doi: 10.6002/ect.2021.0083. Epub 2021 Aug 9.
6
Progressive sarcopenia and myosteatosis predict prognosis of advanced HCC patients treated with immune checkpoint inhibitors.
Front Immunol. 2024 Apr 16;15:1396927. doi: 10.3389/fimmu.2024.1396927. eCollection 2024.
7
Myosteatosis Is Associated With Frailty and Poor Physical Function in Patients Undergoing Liver Transplant Evaluation: A Cohort Study.
Clin Transplant. 2024 Dec;38(12):e70034. doi: 10.1111/ctr.70034.
8
Assessment of magnetic resonance imaging derived fat fraction as a sensitive and reliable predictor of myosteatosis in liver transplant recipients.
HPB (Oxford). 2020 Jan;22(1):102-108. doi: 10.1016/j.hpb.2019.06.006. Epub 2019 Aug 9.
9
Impact of CT-relevant skeletal muscle parameters on post-liver transplantation survival in patients with hepatocellular carcinoma.
Hepatol Int. 2024 Oct;18(5):1516-1527. doi: 10.1007/s12072-024-10708-z. Epub 2024 Jul 14.
10
Reply to Riva et al. Comment on "Gaspari et al. Blood Purification in Hepatic Dysfunction after Liver Transplant or Extensive Hepatectomy: Far from the Best-Case Scenarios. 2024, , 2853".
J Clin Med. 2025 Jan 27;14(3):822. doi: 10.3390/jcm14030822.
本文引用的文献
1
Comment on 'Myosteatosis and Muscle Loss Impact Liver Transplant Outcomes in Male Patients With Hepatocellular Carcinoma' by Lu et al.
J Cachexia Sarcopenia Muscle. 2024 Dec;15(6):2877-2878. doi: 10.1002/jcsm.13620. Epub 2024 Oct 20.
2
Myosteatosis and muscle loss impact liver transplant outcomes in male patients with hepatocellular carcinoma.
J Cachexia Sarcopenia Muscle. 2024 Oct;15(5):2071-2083. doi: 10.1002/jcsm.13554. Epub 2024 Aug 27.
3
The adverse impact of perioperative body composition abnormalities on outcomes after split liver transplantation: a multicenter retrospective cohort study.
Int J Surg. 2024 Jun 1;110(6):3543-3553. doi: 10.1097/JS9.0000000000001303.
4
Prevalence of and Impact on the Outcome of Myosteatosis in Patients with Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis.
Cancers (Basel). 2024 Feb 27;16(5):952. doi: 10.3390/cancers16050952.
5
Prevalence and impact on the outcome of myosteatosis in patients with cirrhosis: a systematic review and meta-analysis.
Hepatol Int. 2024 Apr;18(2):688-699. doi: 10.1007/s12072-023-10632-8. Epub 2024 Feb 8.
6
Association of myosteatosis with treatment response and survival in patients with hepatocellular carcinoma undergoing chemoembolization: a retrospective cohort study.
Sci Rep. 2023 Mar 9;13(1):3978. doi: 10.1038/s41598-023-31184-9.
7
Myosteatosis Is Not Associated with Complications or Survival in HCC Patients Undergoing Trans Arterial Embolization.
J Clin Med. 2022 Dec 29;12(1):262. doi: 10.3390/jcm12010262.
8
Muscle Alterations Are Associated With Minimal and Overt Hepatic Encephalopathy in Patients With Liver Cirrhosis.
Hepatology. 2019 Nov;70(5):1704-1713. doi: 10.1002/hep.30692. Epub 2019 Jun 28.
9
Preoperative Visceral Adiposity and Muscularity Predict Poor Outcomes after Hepatectomy for Hepatocellular Carcinoma.
Liver Cancer. 2019 Mar;8(2):92-109. doi: 10.1159/000488779. Epub 2018 Jun 5.
10
Myosteatosis and sarcopenia are associated with hepatic encephalopathy in patients with cirrhosis.
Hepatol Int. 2018 Jul;12(4):377-386. doi: 10.1007/s12072-018-9875-9. Epub 2018 Jun 7.
Zotero 插件